Treatment of Recurrent Herpes Simplex Labialis with Levamisole
Because deficient immune responses may play a contributory role in recurrent herpes simplex labialis, an immunomodulating agent, levamisole, has been advocated for therapy. Forty-two patients with a high frequency of recurrent herpes simplex labialis were followed for a mean of 7.8 months (range 4 t...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1979
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352734/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/525982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.5.662 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|